Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
25 March 2021A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.
Intensive care unit (ICU) occupancy is likely to increase dramatically over the next few weeks, suggests research published by a team at the University of Cambridge. Their work suggests that if the current exponential growth of COVID-19 infections continues, then within two weeks, five out of seven commissioning regions in England will have more critically ill COVID-19 patients than can be accommodated with ICU beds normally available.
Patients in intensive care units are at significant risk of potentially life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C. difficile. Now, a new test could identify those at greatest risk – and speed up the development of new therapies to help at-risk patients.
Clinical researchers have developed software for interpreting the enormous quantities of data generated by bedside monitors.